arcadia biosciences glp-1 receptor agonist weight management diabetes treatments Clinical of Regain and Cardiometabolic Consequences After Discontinuation of GLP‐1 Agonists - Shah - 2026 - Diabetes, Obesity and Metabolism GLP-1 receptor agonism: a transformative

Metabolic: Euglycemic DKA The risk of euglycemic DKA is very uncommon, but its a clinically important and real complication to be aware of in patients using GLP-1 agonists

Liraglutide could also improve hepatic steatosis and ballooning degeneration in patients with NASH (192)

P T 38 , 525534 (2013)

How Mounjaro Is Helping People With Obesity Lose Weight Mounjaro, a GLP-1 receptor agonist, is helping individuals with obesity lose weight by targeting hunger and improving insulin sensitivity

Rahman, M

The insurer notes future expanded uses could include metabolic dysfunction-associated steatohepatitis and obstructive sleep apnea [Source: ab.bluecross.ca/plans/group/drug-pipeline-2026.php]